Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria

Lancet

Volumn 363, Issue 9405, 2004, Pages 283-289

  Staalsoe, Trine ^a   Shulman, Caroline E ^b,c   Bulmer, Judith N ^d   Kawuondo, Ken ^c   Marsh, Kevin ^c   Hviid, Lars ^a,e  

^a Mental Health Center Glostrup   (Denmark)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN 4 SULFATE; HEMOGLOBIN; IMMUNOGLOBULIN G; MEMBRANE ANTIGEN;

ADHESION; ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CHILDBIRTH; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HEALTH STATUS; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; KENYA; MAJOR CLINICAL STUDY; MALARIA; MEASUREMENT; NONHUMAN; PARASITE ISOLATION; PATIENT SELECTION; PLACENTAL MALARIA; PLASMA; PLASMODIUM FALCIPARUM; PREGNANCY; PRIORITY JOURNAL; PROTECTION; WEIGHT REDUCTION;

EID: 0942268159     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)15386-X     Document Type: Article

References (29)

1. Yamada M., Steketee R., Abramowsky C., et al. Plasmodium falciparum associated placental pathology: a light and electron microscopic and immunohistologic study. Am J Trop Med Hyg. 41:1989;161-168.
2. Fried M., Duffy P.E. Adherence of Plasmodium falciparum to chondroitin sulphate A in the human placenta. Science. 272:1996;1502-1504.
3. Achur R.N., Valiyaveettil M., Alkhalil A., Ockenhouse C.F., Gowda D.C. Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparum-infected erythrocytes to the placenta. J Biol Chem. 275:2000;40344-40356.
4. Brabin B.J. An analysis of malaria in pregnancy in Africa. Bull World Health Organ. 61:1983;1005-1016.
5. Guyatt H.L., Snow R.W. Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa. Trans R Soc Trop Med Hyg. 95:2001;569-576.
6. Shulman C.E., Marshall T., Dorman E.K., et al. Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae. Trop Med Int Health. 6:2001;770-778.
7. Gardner M.J., Hall N., Fung E., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 419:2002;498-511.
8. Kyes S., Horrocks P., Newbold C. Antigenic variation at the infected red cell surface in malaria. Ann Rev Microbiol. 55:2001;673-707.
9. Ricke C.H., Staalsoe T., Koram K., et al. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulphate A. J Immunol. 165:2000;3309-3316.
10. Staalsoe T., Megnekou R., Fievet N., et al. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum infected erythrocytes that are associated with protection against placental parasitemia. J Infect Dis. 184:2001;618-626.
11. O'Neill-Dunne I., Achur R.N., Agbor-Enoh S.T., et al. Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect Immun. 69:2001;7487-7492.
12. Fried M., Nosten F., Brockman A., Brabin B.T., Duffy P.E. Maternal antibodies block malaria. Nature. 395:1998;851-852.
13. Bulmer J.N., Rasheed F.N., Francis N., Morrison L., Greenwood B.M. Placental malaria. I. Pathological classification. Histopathology. 22:1993;211-218.
14. Salanti A., Staalsoe T., Lavstsen T., et al. Selective upregulation of a single distinctly structured var gene in CSA-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol. 49:2003;179-191.
15. Staalsoe T., Giha H.A., Dodoo D., Theander T.G., Hviid L. Detection of antibodies to variant antigens on Plasmodium falciparum infected erythrocytes by flow cytometry. Cytometry. 35:1999;329-336.
16. Nguyen-Dinh P., Steketee R.W., Greenberg A.E., Wirima J.J., Mulenda O., Williams S.B. Rapid spontaneous postpartum clearance of Plasmodium falciparum parasitaemia in African women. Lancet. 2:1988;751-752.
17. Ofori M.F., Staalsoe T., Bam V., et al. Expression of variant surface antigens by Plasmodium falciparum parasites in the peripheral blood of clinically immune pregnant women indicates ongoing placental infection. Infect Immun. 71:2003;1584-1586.
18. Steketee R.W., Wirima J.J., Bloland P.B., et al. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg. 55:(suppl 1):1996;42-49.
19. Beeson J.G., Cooke B.M., Rowe J.A., Rogerson S.J. Expanding the paradigms of placental malaria. Trends Parasitol. 18:2002;145-147.
20. Duffy P.E., Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect Immun. 71:2003;6620-6623.
21. Guyatt H.L., Snow R.W. The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. Am J Trop Med Hyg. 64:2001;36-44.
22. Garner P., Gülmezoglu A.M. Drugs for preventing malaria-related illness in pregnant women and death in the newborn (Cochrane Review). The Cochrane Library, Issue 2. 2003;Update Software, Oxford.
23. Bull P.C., Lowe B.S., Kortok M., Molyneux C.S., Newbold C.I., Marsh K. Parasite antigens on the infected red cell are targets for naturally acquired immunity to malaria. Nature Med. 4:1998;358-360.
24. Ofori M.F., Dodoo D., Staalsoe T., et al. Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens. Infect Immunol. 70:2002;2982-2988.
25. Okoko B.J., Enwere G., Ota M.O. The epidemiology and consequences of maternal malaria: a review of immunological basis. Acta Trop. 87:2003;193-205.
26. Buffet P.A., Gamain B., Scheidig C., et al. Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection. Proc Natl Acad Sci USA. 96:1999;12743-12748.
27. Reeder J.C., Cowman A.F., Davern K.M., et al. The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P falciparum erythrocyte membrane protein 1. Proc Natl Acad Sci USA. 96:1999;5198-5202.
28. Rowe J.A., Kyes S.A., Rogerson S.J., Babiker H.A., Raza A. Identification of a conserved Plasmodium falciparum var gene implicated in malaria in pregnancy. J Infect Dis. 185:2002;1207-1211.
29. Salanti A., Jensen A.T.R., Zornig H.D., et al. A sub-family of common and highly conserved var genes expressed by CSA-adhering Plasmodium falciparum. Mol Biochem Parasitol. 122:2002;111-115.